|
 |
Pharmaceutical Manufacturing and Packing Sourcer
|
The pharmaceutical sector is a multi-million pound business for suppliers of coding and marking solutions. However by its very nature it is an industry which presents many specific challenges. In this article, we examine the coding and marking issues that have to be addressed and talk about some of the solutions on offer.
The pharmaceutical industry is perhaps one of the most demanding areas when it comes to coding and marking. It is heavily regulated to ensure that products are clearly and accurately coded with traceability and end consumer information. Pharmaceutical companies are regularly and rigorously audited to ensure compliance with Food and Drug Administration (FDA) rules. In addition, they face a continuing rise in counterfeit drugs. Against this backdrop, pharmaceutical manufacturers look to suppliers of coding and marking equipment to provide solutions which not only meet their requirements today, but will remain in step with the developing needs of this sector.
The Challenges
The decision to purchase coding and marking systems is largely driven by legislation. FDA laws, which apply internationally in order to provide end user safety, require the use of traceability codes to track products back to their original production batch. This enables swift action to be taken in the event that a recall of a batch of drugs is necessary. Codes such as use by dates are also a key requirement. |
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
4th Annual Patient Recruitment and Retention in Clinical Trials
13-15 October 2008, Amsterdam
Patient recruitment
is now consuming thirty percent of clinical trial time - more time than any
other clinical trial activity - and almost half of all trial delays result from
patient recruitment problems.
As the
recruiting culture becomes more sophisticated and the forces affecting patient
enrollment grow more numerous and complex, pharmaceutical companies are
striving to discover new strategies to facilitate enrollment in clinical
trials.
With
increasing industry pressure to develop, test and market greater numbers of new
drugs faster, pharmaceutical companies need to perform clinical trials as
quickly as possible. Inefficient patient recruitment processes is a formidable
barrier to pharmaceutical companies' success in launching new products.
Improving the patient recruitment process is imperative to avoid wasted
investments and eliminate costly delays in bringing new drugs to market --
today and even more so in the not-so-distant future. Improved patient
recruitment presents one of the largest opportunities for pharmaceutical
companies to eliminate delays in clinical trials, thereby making it possible to
reduce time to market. With patent time limits and large overheads
meaning that any delays in the development timeline can be disastrous, a good
understanding of how to successfully recruit patients for trials is vital for
any company looking to succeed.
More info >> |
|
 |
News and Press Releases |
 |
Ultra slim and ultra quick
More info >>
|
|
 |
